Role of serum calprotectin in identifying familial Mediterranean fever attacks

Gucenmez OA, Kume T, Makay B et al (2018) Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever. Int J Rheum Dis 21:1844–1848. https://doi.org/10.1111/1756-185X.13396

Article  CAS  PubMed  Google Scholar 

Yalçınkaya F, Özen S, Özçakar Z et al (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48(4):395–398

Article  PubMed  Google Scholar 

Korkmaz C, Özdogan H, Kasapçopur Ö et al (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61(1):79–81

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lachmann H, Şengül B, Yavuzşen TU et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology 45(6):746–750. https://doi.org/10.1093/rheumatology/kei279

Article  CAS  PubMed  Google Scholar 

Shohat M, Halpern GJ (2011) Familial Mediterranean fever a review. Genet Med 13(6):487–498

Article  PubMed  Google Scholar 

Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467–478. https://doi.org/10.1111/J.1365-2141.2009.07733.X

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gumucio DL, Diaz A, Schaner P et al (2002) Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 20(4; SUPP/26):45–53

Google Scholar 

Chae J, Wood G, Richard K et al (2008) The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-κB through its N-terminal fragment. The Journal of the American Society of Hematology 112(5):1794–1803

CAS  Google Scholar 

Nishikawa Y, Kajiura Y, Lew JH et al (2017) Calprotectin induces IL-6 and MCP-1 production via toll-like receptor 4 signaling in human gingival fibroblasts. J Cell Physiol 232:1862–1871. https://doi.org/10.1002/jcp.25724

Article  CAS  PubMed  Google Scholar 

Garcia V, Perera Y, Biomolecules WC et al (2022) A structural perspective on calprotectin as a ligand of receptors mediating inflammation and potential drug target. Biomolecules 12(4):519

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kopeć-Mędrek M, Widuchowska M, Kucharz EJ (2016) Calprotectin in rheumatic diseases: a review. Reumatologia 54(6):306. https://doi.org/10.5114/reum.2016.64907

Article  PubMed  PubMed Central  Google Scholar 

Kılıçaslan E, Düzenli T, Çelik S et al (2022) Assessment of serum resistin and plasma calprotectin levels as biomarkers of ınflammation in patients with familial Mediterranean fever disease. Mediterr J Rheumatol 33:322. https://doi.org/10.31138/MJR.33.3.322

Article  PubMed  PubMed Central  Google Scholar 

Asan G, Derin ME, Doğan HO et al (2020) Can calprotectin show subclinical inflammation in familial Mediterranean fever patients. J Korean Med Sci 35(10):e63. https://doi.org/10.3346/jkms.2020.35.e63

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dzhndoian Z (2012) Serum levels of myeloıd-related proteın Mrp 8/14 (calprotectın) ın Armenıan patıents wıth famılıal Medıterranean fever (FMF). Ter Arkh 84(6):45–48

CAS  PubMed  Google Scholar 

Holzinger D, Roth J (2016) Alarming consequences–autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1. Rheumatology J 28(5):550–559. https://doi.org/10.1097/BOR.0000000000000314

Article  CAS  Google Scholar 

Jorch SK, McNally A, Berger P et al (2023) Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever. J Allergy Clin Immunol 152:230–243. https://doi.org/10.1016/J.JACI.2023.01.03

Article  CAS  PubMed  Google Scholar 

Neogi T, Aletaha D, Silman AJ et al (2010) The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 62:2582–2591. https://doi.org/10.1002/ART.27580

Article  PubMed  PubMed Central  Google Scholar 

Kalla R, Kennedy NA, Ventham NT et al (2016) Serum calprotectin: a novel diagnostic and prognostic marker in inflammatory bowel diseases. Am J Gastroenterol Suppl. 111(12):1796–1805. https://doi.org/10.1038/ajg.2016.342

Article  CAS  Google Scholar 

Unal I (2017) Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med 2017:3762651. https://doi.org/10.1155/2017/3762651

Article  PubMed  PubMed Central  Google Scholar 

Fangyu L, Hua H (2018) Assessing the accuracy of diagnostic tests. Shanghai Arch Psychiatry 30(3):207

Google Scholar 

Jung S, Park Y, Ha Y et al (2006) Serum calprotectin as a marker for disease activity and severity in adult-onset Still’s disease. J Rheumatol 8(3):1–12

Google Scholar 

Arias MG, Pascual-Salcedo D, Ueberschlag M-E et al (2013) Calprotectin in rheumatoid arthritis: association with disease activity in a cross-sectional and a longitudinal cohort. Mol Diagn Ther 17:49–56. https://doi.org/10.1007/s40291-013-0016-9

Article  CAS  Google Scholar 

Oktayoglu P, Bozkurt M, Mete N et al (2014) Elevated serum levels of calprotectin (myeloid-related protein 8/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life. J Investig Med 62:880–884. https://doi.org/10.1097/JIM.0000000000000095

Article  CAS  PubMed  Google Scholar 

Inciarte-Mundo J, Ramirez J, Hernández MV et al (2016) Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity. Arthritis Res Ther 8(1):160. https://doi.org/10.1186/S13075-016-1032-Z

Article  Google Scholar 

Nordal HH, Brun JG, Halse AK et al (2014) Calprotectin (S100A8/A9), S100A12, and EDTA-resistant S100A12 complexes (ERAC) in primary Sjögren’s syndrome Scandinavian. J Rheumatol 43(1):76–78. https://doi.org/10.3109/03009742.2013.848930

Article  CAS  Google Scholar 

Frosch M, Ahlmann M, Vogl T et al (2009) The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 60:883–891. https://doi.org/10.1002/ART.24349

Article  CAS  PubMed  Google Scholar 

Haga HJ, Brun JG, Berntzen HB et al (1993) Calprotection in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 2:47–50. https://doi.org/10.1177/096120339300200108

Article  CAS  PubMed  Google Scholar 

Demirbaş F, Çaltepe G, Comba A et al (2019) Fecal calprotectin in children with familial Mediterranean fever in the attack-free period. Pediatr Int 61:1140–1145. https://doi.org/10.1111/PED.13995

Article  PubMed  Google Scholar 

Tezcan D, Onmaz DE, Sivrikaya A et al (2023) Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever. Ir J Med Sci 192:2015–2022. https://doi.org/10.1007/s11845-022-03173-w/fıgures/1

Article  CAS  PubMed  Google Scholar 

Bae SC, Lee YH (2017) Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. Postgrad Med 129:531–537. https://doi.org/10.1080/00325481.2017.1319729

Article  PubMed  Google Scholar 

Jarlborg M, Courvoisier DS, Lamacchia C et al (2020) Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther 22:1–11. https://doi.org/10.1186/s13075-020-02190-3/tables/4

Article  Google Scholar 

留言 (0)

沒有登入
gif